Synthesis and evaluation of O-(3-[18F] fluoropropyl)-L-tyrosine as an oncologic PET tracer

被引:30
作者
Tang, GH [1 ]
Wang, MF
Tang, XL
Luo, L
Gan, MQ
机构
[1] First Mil Med Univ, Nan Fang Hosp, Nan Fang PET Ctr, Guangzhou 510515, Peoples R China
[2] S China Agr Univ, Dept Appl Chem, Guangzhou 510642, Peoples R China
关键词
O-(3-[F-18]fluoropropyl)-L-tyrosine; O-(2-[F-18]fluoroethyl)-L-tyrosine; F-18]fluorine-2-deoxy-D-glucose; experimental tumor; inflammation;
D O I
10.1016/S0969-8051(03)00097-0
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
O-(3-[F-18]fluoropropyl)-L-tyrosine (FPT), an analogue of O-(2-[F-18]fluoroethyl)-L-tyrosine (FET) as an amino acid tracer for tumor imaging with positron emission tomography (PET), was synthesized and evaluated. FPT was prepared by [F-18]fluoropropylation of L-tyrosine in a two-step procedure. Biodistribution of FPT was determined in normal mice. FPT, FET and [F-18]fluorine-2-deoxy-D-glucose (FDG) uptake studies were performed in mice bearing S 18 fibrosarcoma and S. aureus-inoculated mice. Also, carcinoma-bearing mice and S. aureus-inoculated mice were imaged using FPT PET imaging compared with FET and FDG PET imaging. Synthesis of FPT was accompished in about 60 min with an overall radiochemical yield of 25-30% (without decay correction) by manual operation. High uptake and long retention time of FPT and FET in kidney, liver, lung, blood, etc., and low uptake in brain were found. Furthermore, high FPT, FET and FDG uptake in tumor, and almost no FPT and FET uptake in inflammatory tissue, in contrast, high FDG uptake in inflammatory tissue, were observed. In conclusion, FPT is easy to prepare and superior to FDG in the differentiation of tumor and inflammation, and seems to be a potential amino acid tracer like FET for tumors imaging with PET. (C) 2003 Elsevier Inc. All rights reserved.
引用
收藏
页码:733 / 739
页数:7
相关论文
共 20 条
[1]   18F-labeled FECNT:: A selective radioligand for PET imaging of brain dopamine transporters [J].
Goodman, MM ;
Kilts, CD ;
Keil, R ;
Shi, B ;
Martarello, L ;
Xing, DX ;
Votaw, J ;
Ely, TD ;
Lambert, P ;
Owens, MJ ;
Camp, VM ;
Malveaux, E ;
Hoffman, JM .
NUCLEAR MEDICINE AND BIOLOGY, 2000, 27 (01) :1-12
[2]  
Hamacher K., 2001, Journal of Labelled Compounds and Radiopharmaceuticals, V44, pS855
[3]   Efficient routine production of the 18F-labelled amino acid O-(2-[18F]fluoroethyl)-L-tyrosine [J].
Hamacher, K ;
Coenen, HH .
APPLIED RADIATION AND ISOTOPES, 2002, 57 (06) :853-856
[4]  
Heiss P, 1999, J NUCL MED, V40, P1367
[5]  
Jager PL, 2001, J NUCL MED, V42, P432
[6]   18F-FDG and 18F-FET uptake in experimental soft tissue infection [J].
Kaim, AH ;
Weber, B ;
Kurrer, MO ;
Westera, G ;
Schweitzer, A ;
Gottschalk, J ;
von Schulthess, GK ;
Buck, A .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2002, 29 (05) :648-654
[7]  
Kazumata K, 1998, J NUCL MED, V39, P1521
[8]   Fluorinated amino acids for tumour imaging with positron emission tomography [J].
Laverman, P ;
Boerman, OC ;
Corstens, FHM ;
Oyen, WJG .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2002, 29 (05) :681-690
[9]   N-substituted analogs of 2 beta-carbomethoxy-3 beta-(4'-iodophenyl)tropane (beta-CIT) with selective affinity to dopamine or serotonin transporters in rat forebrain [J].
Neumeyer, JL ;
Tamagnan, G ;
Wang, SY ;
Gao, YG ;
Milius, RA ;
Kula, NS ;
Baldessarini, RJ .
JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (02) :543-548
[10]  
PIKE VW, 1997, DRUG INF J, V31, P997